Article info

Download PDFPDF
Original research
Plasma neurofilament light chain levels suggest neuroaxonal stability following therapeutic remyelination in people with multiple sclerosis

Authors

  • Ahmed Abdelhak Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco (UCSF), San Francisco, California, USA PubMed articlesGoogle scholar articles
  • Christian Cordano Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco (UCSF), San Francisco, California, USA PubMed articlesGoogle scholar articles
  • W John Boscardin Departments of Medicine and Epidemiology & Biostatistics, University of California at San Francisco, San Francisco, California, USA PubMed articlesGoogle scholar articles
  • Eduardo Caverzasi Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco (UCSF), San Francisco, California, USA PubMed articlesGoogle scholar articles
  • Jens Kuhle Multiple Sclerosis Centre, Neurology, Departments of Head, Spine and Neuromedicine, Biomedicine and Clinical Research, University Hospital Basel and University of Basel, Basel, SwitzerlandResearch Center for Clinical Neuroimmunology and Neuroscience (RC2NB), University Hospital and University of Basel, Basel, Switzerland PubMed articlesGoogle scholar articles
  • Brandon Chan Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco (UCSF), San Francisco, California, USA PubMed articlesGoogle scholar articles
  • Jeffrey M Gelfand Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco (UCSF), San Francisco, California, USA PubMed articlesGoogle scholar articles
  • Hao H Yiu Department of Biology, University of Maryland, College Park, Maryland, USA PubMed articlesGoogle scholar articles
  • Frederike C Oertel Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco (UCSF), San Francisco, California, USA PubMed articlesGoogle scholar articles
  • Alexandra Beaudry-Richard Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco (UCSF), San Francisco, California, USA PubMed articlesGoogle scholar articles
  • Shivany Condor Montes Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco (UCSF), San Francisco, California, USA PubMed articlesGoogle scholar articles
  • Jorge R Oksenberg Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco (UCSF), San Francisco, California, USA PubMed articlesGoogle scholar articles
  • Argentina Lario Lago Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco (UCSF), San Francisco, California, USA PubMed articlesGoogle scholar articles
  • Adam Boxer Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco (UCSF), San Francisco, California, USA PubMed articlesGoogle scholar articles
  • Julio C Rojas-Martinez Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco (UCSF), San Francisco, California, USA PubMed articlesGoogle scholar articles
  • Fanny M Elahi Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco (UCSF), San Francisco, California, USA PubMed articlesGoogle scholar articles
  • Jonah R Chan Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco (UCSF), San Francisco, California, USA PubMed articlesGoogle scholar articles
  • Ari J Green Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco (UCSF), San Francisco, California, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Ari J Green, Department of Neurology, University of California San Francisco, San Francisco, CA 94117, USA; agreen{at}ucsf.edu
View Full Text

Citation

Abdelhak A, Cordano C, Boscardin WJ, et al
Plasma neurofilament light chain levels suggest neuroaxonal stability following therapeutic remyelination in people with multiple sclerosis

Publication history

  • Received March 8, 2022
  • Accepted May 23, 2022
  • First published June 16, 2022.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.